Title:
COMPOSITION OF INTESTINAL FLORA MODULATOR AND MESENCHYMAL STEM CELLS AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/189558
Kind Code:
A1
Abstract:
Provided are a composition of an intestinal flora modulator and mesenchymal stem cells and the use thereof. The composition can effectively enhance the therapeutic effect of the mesenchymal stem cells on diabetes, particularly autoimmune type I diabetes, and can alleviate pancreatic islet-related inflammations, so that more pancreatic islet beta cells can be preserved.
Inventors:
ZHANG YI (CN)
XIAO E (CN)
LYU WANQI (CN)
XIAO E (CN)
LYU WANQI (CN)
Application Number:
PCT/CN2020/084292
Publication Date:
September 30, 2021
Filing Date:
April 10, 2020
Export Citation:
Assignee:
PEKING UNIV SCHOOL AND HOSPITAL OF STOMATOLOGY (CN)
International Classes:
C12N5/0775; A61K35/28; A61K35/50; A61K35/51; A61K35/741; A61K35/745; A61K45/06; A61P3/10; A61P37/02; C12N1/20; C12R1/01
Domestic Patent References:
| WO2016093863A1 | 2016-06-16 | |||
| WO2015081410A1 | 2015-06-11 |
Foreign References:
| CN110564643A | 2019-12-13 | |||
| CN102711799A | 2012-10-03 | |||
| CN102066555A | 2011-05-18 |
Attorney, Agent or Firm:
BEIJING WANHUIDA LAW FIRM (CN)
Download PDF: